These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2146707)

  • 1. Evaluation of 3H-paroxetine as a radioligand for in vivo study of 5-hydroxytryptamine uptake sites in mouse brain.
    Hashimoto K; Goromaru T
    Radioisotopes; 1990 Aug; 39(8):335-41. PubMed ID: 2146707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo labeling of 5-hydroxytryptamine uptake sites in mouse brain with [3H]-6-nitroquipazine.
    Hashimoto K; Goromaru T
    J Pharmacol Exp Ther; 1990 Oct; 255(1):146-53. PubMed ID: 2213550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo labeling of serotonin uptake sites with [3H]paroxetine.
    Scheffel U; Hartig PR
    J Neurochem; 1989 May; 52(5):1605-12. PubMed ID: 2523469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of 3H-paroxetine as a radiopharmaceutical for lung function].
    Hashimoto K; Goromaru T
    Kaku Igaku; 1989 Jul; 26(7):879-85. PubMed ID: 2530375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites.
    Laruelle M; Vanisberg MA; Maloteaux JM
    Biol Psychiatry; 1988 Jul; 24(3):299-309. PubMed ID: 2969755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine.
    Hashimoto K; Goromaru T
    Neuropharmacology; 1990 Jul; 29(7):633-9. PubMed ID: 1696701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
    De Souza EB; Kuyatt BL
    Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.
    Hirano K; Maruyama S; Kimura R; Kagawa Y; Yamada S
    Life Sci; 2004 Oct; 75(24):2933-45. PubMed ID: 15454344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
    Dewar KM; Reader TA; Grondin L; Descarries L
    Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional distribution of serotonergic pre- and postsynaptic markers in human brain.
    Laruelle M; Maloteaux JM
    Acta Psychiatr Scand Suppl; 1989; 350():56-9. PubMed ID: 2530792
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition and dissociation of [3H]-paroxetine binding to human platelets.
    Andersson A; Marcusson J
    Neuropsychobiology; 1989; 22(3):135-40. PubMed ID: 2535005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of [3H]paroxetine binding to the 5-hydroxytryptamine uptake site in an animal model of depression.
    Edwards E; Harkins K; Wright G; Henn F
    J Neurochem; 1991 May; 56(5):1581-6. PubMed ID: 1826517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue.
    Bäckström I; Bergström M; Marcusson J
    Brain Res; 1989 May; 486(2):261-8. PubMed ID: 2525060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO; Bergström M; Eriksson K; Ross SB
    J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated electroconvulsive shock does not change [3H]-paroxetine binding to the 5-HT uptake site in rat cortical membranes.
    Gleiter CH; Nutt DJ
    Psychopharmacology (Berl); 1988; 95(1):68-70. PubMed ID: 2838861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet [3H]paroxetine binding to 5-HT uptake sites in Alzheimer's disease.
    Andersson A; Adolfsson R; Eriksson K; Marcusson J
    Neurobiol Aging; 1991; 12(5):531-4. PubMed ID: 1837595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo labelling of the mouse brain 5-hydroxytryptamine1A receptor with the novel selective antagonist 3H-NAD-299.
    Stenfors C; Werner T; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):500-7. PubMed ID: 9650801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.
    Plenge P; Mellerup ET; Laursen H
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):61-72. PubMed ID: 2137251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.